Mirus Bio™ TransIT™-Keratinocyte Transfection Reagent

TransIT™-Keratinocyte Transfection Reagent designed for highly efficient, low-toxicity DNA transfection in primary keratinocytes. Transfection does not required medium changes and can be carried out in serum-containing medium.

Supplier:  Mirus Bio™ MIR 2800

Catalog No. MIR2800

Includes: TransIT-Keratinocyte transfection reagent, supplied as a ready-to-use solution.

Description

• TransIT-Keratinocyte transfection reagent, supplied as a ready-to-use solution.
• Optimized transfection performance in keratinocyte cells.
• Low cellular toxicity maintains cell density and reduces experimental bias.
• Allows 20 to 30% transfection efficiency in keratinocytes.
• Concentration: 1.37 mg/mL

Specifications

• Cell Type: Mammalian
• Promoter: None (Promoterless)
• Concentration: 1.37 mg/mL
• Product Type: Transfection Reagent
• Sterility: Sterile

• Format: Tube
• Transfection Technique: Chemical Transfection
• For Use With (Application): Highly efficient DNA or RNA transfection with minimal cellular toxicity, specifically for primary keratinocytes
• Quantity: 1 mL